IP Library Granted Patent US 8,940,317
Granted Patent B2
US 8,940,317 · App. 13/722,237 · Granted Jan 27, 2015

Continuous matrix with osteoconductive particles dispersed therein, method of forming thereof, and method of regenerating bone therewith

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,317
App. No.
13/722,237
Granted
Jan 27, 2015
Kind
B2
Abstract

The present disclosure provides compositions useful in regeneration of connective tissue, particularly bone. The compositions comprise a continuous matrix formed of a polypeptide crosslinked with a second polymer and further comprise particles of a porous, osteoconductive material dispersed in the continuous matrix. The composition can be provided in a dehydrated form. The disclosure further provides methods of preparing the composition in a clinically useful form, methods of using the composition in regenerating bone, and kits including the composition.

Claims (15)

1. A method of preparing a bone void filler composition, the method comprising:

combining particles of a porous, osteoconductive material with a solution of a polypeptide to form a slurry; and

adding to the slurry a second polymer under conditions such that the polypeptide crosslinks with the second polymer to form a continuous matrix having the particles of the osteoconductive material dispersed therein;

wherein before said adding step, at least a portion of the pores in the particles of the osteoconductive material have a biocompatible material adsorbed therein.

2. The method according to claim 1 , wherein the biocompatible material adsorbed in the pores of the osteoconductive particles comprises the polypeptide used to form the slurry.

3. The method according to claim 1 , wherein the second polymer is a polysaccharide.

4. The method according to claim 1 , wherein the second polymer is a synthetic polymer.

5. The method according to claim 1 , wherein the second polymer is at least partially solubilized prior to said adding step.

6. The method according to claim 1 , further comprising adding a scaffolding reagent or an osteoinductive material to the composition.

7. The method according to claim 6 , comprising adding a scaffolding reagent selected from the group consisting of polar amino acids, divalent cation chelators, and combinations thereof.

8. The method according to claim 6 , comprising adding bone marrow aspirates as the osteoinductive material.

9. The method according to claim 1 , wherein the polypeptide comprises gelatin.

10. The method according to claim 1 , wherein the porous, osteoconductive material is selected from the group consisting of calcium phosphate, calcium sulfate, calcium aluminate, alumina, zirconia, aluminum silicates, polypropylene fumarate, bioactive glass, porous titanium, porous nickel-titanium alloy, porous tantalum, sintered cobalt-chrome beads, autologous bone, allogenic bone, xenogenic bone, corallin, and combinations thereof.

11. The method according to claim 1 , comprising combining the particles of the porous, osteoconductive material, the polypeptide, and the second polymer such that the particles and the continuous matrix are present in a dry weight ratio of about 90:10 to about 50:50.

12. The method according to claim 1 , further comprising dehydrating the composition.

Assignments (13)
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 068539/0492 →
SECURITY INTEREST Recorded Aug 11, 2024
From: XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.; SURGALIGN SPV, INC.; XTANT MEDICAL HOLDINGS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 068539/0665 →
SECURITY AGREEMENT SUPPLEMENT (TERM) Recorded Dec 22, 2023
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 066095/0635 →
SECURITY AGREEMENT SUPPLEMENT (REVOLVING) Recorded Dec 22, 2023
From: XTANT MEDICAL HOLDINGS, INC.; XTANT MEDICAL, INC.; BACTERIN INTERNATIONAL, INC.; X-SPINE SYSTEMS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 066095/0652 →
MERGER Recorded Oct 19, 2023
From: PIONEER SURGICAL TECHNOLOGY, INC.
To: PIONEER SURGICAL TECHNOLOGY NEWCO, INC.
Reel/Frame 065287/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 11, 2023
From: PIONEER SURGICAL TECHNOLOGY NEWCO, INC.
To: XTANT MEDICAL HOLDINGS, INC.
Reel/Frame 065218/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 4, 2021
From: HILL, RONALD STEWART; LAMBERTI, FRANCIS VINCENT; MACMILLAN, ADAM; SCHLOSSBERG, BRIAN; CAPISTRON, STEPHEN; LLOYD, WILLIAM H.
To: PIONEER SURGICAL TECHNOLOGY, INC.
Reel/Frame 055153/0050 →
RELEASE OF SECURITY INTEREST Recorded Jul 21, 2020
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
Reel/Frame 053260/0398 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: ARES CAPITAL CORPORATION, AS AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
Reel/Frame 053257/0652 →
SECURITY INTEREST Recorded Mar 8, 2019
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048543/0505 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: PIONEER SURGICAL TECHNOLOGY, INC.
Reel/Frame 046320/0040 →
SECURITY INTEREST Recorded Jun 6, 2018
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS THE ADMINISTRATIVE AGENT
Reel/Frame 046303/0926 →
SECURITY AGREEMENT Recorded Jul 29, 2013
From: PIONEER SURGICAL TECHNOLOGY, INC.
To: TD BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 030892/0193 →